• What Is AGGRENOX?
• Taking AGGRENOX to Reduce Stroke Risk
• Safety and Side Effects
• Aggrenox Rx Cost Savings

What Is AGGRENOX?

AGGRENOX is an FDA-approved prescription medication to lower the risk of stroke in people who have had either a TIA (transient ischemic attack or “mini-stroke”) or stroke due to a blood clot.

AGGRENOX is proven to be effective:

In a clinical study, AGGRENOX helped reduce the risk of stroke in patients who had a TIA or stroke due to a blood clot.

• Patients taking AGGRENOX twice daily were 22% less likely to have stroke than patients taking low-dose aspirin (25 mg twice daily) alone.
• Over 90% of patients on AGGRENOX remained free of recurrent stroke.

Learn about the study.

ESPS2 (European Stroke Prevention Study) was a 24-month study in which 6602 patients over the age of 18 had an ischemic stroke or TIA (“mini-stroke” or transient ischemic attack) within 3 months prior to entry.

Patients received treatment with either AGGRENOX (aspirin/extended-release dipyridamole); extended-release dipyridamole (200 mg alone); aspirin (25 mg alone); or a sugar pill (placebo) twice daily (morning and evening).